Endoscopic dilation combined with bleomycin injection for managing benign anastomotic stricture after gastrointestinal surgery

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900022769

Enrollment

Unknown

Registered

2019-04-25

Start date

2019-08-01

Completion date

Unknown

Last updated

2019-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

benign anastomotic stricture after gastrointestinal surgery

Interventions

Control group:Endoscopic dilation

Experimental group:Endoscopic dilation combined with bleomycin injection

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) difficulty with bowel movements, constipation or abdominal distension after anus-retained operation of rectal cancer. (2) colonoscope couldnt pass through the anastomotic site. (3) the anastomotic stricture was proved benign.

Exclusion criteria

Exclusion criteria: (1) anastomotic abscess or fistula. (2) severe comorbidities, such as coagulation disorders, cardiopulmonary dysfunction.

Design outcomes

Primary

Measure	Time frame
The diameter of the anastomotic site;Re-intervention interval;	—

Countries

China

Contacts

Public ContactZhining Fan

Jiangsu Province Hospital

fanzhining@njmu.edu.cn+86 13951965080

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026